Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sage Plans New Trials And Approval Timeline For Zuranolone
Company Will Explore A Higher Dose For The Antidepressant
Mar 18 2020
•
By
Jessica Merrill
Sage sees a longer, but straightforward path for zuranolone • Source: Shutterstock
More from Neurological
More from Therapeutic Category